- Previous Close
0.0270 - Open
0.0280 - Bid 0.0250 x --
- Ask 0.0270 x --
- Day's Range
0.0270 - 0.0280 - 52 Week Range
0.0220 - 0.1300 - Volume
237,253 - Avg. Volume
103,524 - Market Cap (intraday)
9.597M - Beta (5Y Monthly) 0.31
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0400 - Earnings Date Feb 20, 2025 - Feb 24, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Sep 4, 2020
- 1y Target Est
--
Zoono Group Limited, together with its subsidiaries, engages in the research, development, and sale of a range of antimicrobial products in New Zealand, Australasia, Asia, the United States, India, the United Kingdom, and Europe. Its products include hand and surface sanitisers, textile applicator, and mould remediation products. The company serves facilities management, transportation, education, hospitality, and healthcare sectors. Zoono Group Limited was founded in 2007 and is headquartered in Auckland, New Zealand.
zoono.com--
Full Time Employees
June 30
Fiscal Year Ends
Sector
Industry
Recent News: ZNO.AX
View MorePerformance Overview: ZNO.AX
Trailing total returns as of 1/17/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ZNO.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ZNO.AX
View MoreValuation Measures
Market Cap
9.60M
Enterprise Value
8.53M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.17
Price/Book (mrq)
1.54
Enterprise Value/Revenue
8.88
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-44.07%
Return on Equity (ttm)
-101.70%
Revenue (ttm)
1.05M
Net Income Avi to Common (ttm)
-9.09M
Diluted EPS (ttm)
-0.0400
Balance Sheet and Cash Flow
Total Cash (mrq)
1.96M
Total Debt/Equity (mrq)
11.64%
Levered Free Cash Flow (ttm)
601.37k